Natrecor Use Should Be Limited, Independent Panel Convened By J&J Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.